Jeong H, Cho H, Kim H, et al. Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis. Blood Adv. 2021;5(8):2142-2152.

On page 2143, under “Treatment and response assessment,” the units for the dose of high-dose methotrexate (HD-MTX) should be expressed as 3 to 3.5 g/m² and not 3 to 3.5 mg/m².